[go: up one dir, main page]

ZA975448B - Cyclosporin-containing soft capsule preparations - Google Patents

Cyclosporin-containing soft capsule preparations

Info

Publication number
ZA975448B
ZA975448B ZA975448A ZA975448A ZA975448B ZA 975448 B ZA975448 B ZA 975448B ZA 975448 A ZA975448 A ZA 975448A ZA 975448 A ZA975448 A ZA 975448A ZA 975448 B ZA975448 B ZA 975448B
Authority
ZA
South Africa
Prior art keywords
cyclosporin
soft capsule
containing soft
capsule preparations
preparations
Prior art date
Application number
ZA975448A
Other languages
English (en)
Inventor
Jong Soo Woo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA975448B publication Critical patent/ZA975448B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
ZA975448A 1996-06-19 1997-06-19 Cyclosporin-containing soft capsule preparations ZA975448B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960022417A KR0183449B1 (ko) 1996-06-19 1996-06-19 사이클로스포린-함유 연질캅셀제

Publications (1)

Publication Number Publication Date
ZA975448B true ZA975448B (en) 1999-03-19

Family

ID=19462548

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975448A ZA975448B (en) 1996-06-19 1997-06-19 Cyclosporin-containing soft capsule preparations

Country Status (17)

Country Link
EP (1) EP0813876B1 (xx)
JP (2) JP2855135B2 (xx)
KR (1) KR0183449B1 (xx)
CN (1) CN1180840C (xx)
AR (1) AR013586A1 (xx)
AT (1) ATE214937T1 (xx)
CO (1) CO4970826A1 (xx)
DE (1) DE69711267T2 (xx)
DK (1) DK0813876T3 (xx)
ES (1) ES2175217T3 (xx)
HK (1) HK1006780A1 (xx)
ID (1) ID18517A (xx)
PE (1) PE97198A1 (xx)
PL (1) PL188986B1 (xx)
PT (1) PT813876E (xx)
SI (1) SI0813876T1 (xx)
ZA (1) ZA975448B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980073479A (ko) * 1997-03-14 1998-11-05 한스루돌프하우스, 니콜케르커 사이클로스포린-함유 연질캅셀제
KR19990047897A (ko) * 1997-12-05 1999-07-05 김충환 사이클로스포린 함유 약학적 조성물
PL348193A1 (en) 1998-12-11 2002-05-06 Pharmasolutions Self-emulsifying compositions for drugs poorly soluble in water
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
GB2391472B (en) * 2002-08-02 2004-12-08 Satishchandra Punambhai Patel Pharmaceutical compositions
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
ES2496102T3 (es) * 2003-03-28 2014-09-18 Sigmoid Pharma Limited Forma de dosificación oral sólida que contiene microcápsulas sin fisuras
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
DK2079456T3 (da) 2007-04-04 2013-03-18 Sigmoid Pharma Ltd Farmaceutiske cyclosporinsammensætninger
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
TW200932240A (en) * 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
AU2015258840B2 (en) * 2014-05-15 2018-03-15 Enzychem Lifesciences Corporation Methods for treating leukopenia and thrombocytopenia
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물

Also Published As

Publication number Publication date
CO4970826A1 (es) 2000-11-07
DK0813876T3 (da) 2002-07-22
PE97198A1 (es) 1999-01-13
DE69711267D1 (de) 2002-05-02
PL188986B1 (pl) 2005-05-31
JPH107550A (ja) 1998-01-13
PT813876E (pt) 2002-07-31
EP0813876B1 (en) 2002-03-27
ES2175217T3 (es) 2002-11-16
CN1180840C (zh) 2004-12-22
HK1006780A1 (en) 1999-03-19
AR013586A1 (es) 2001-01-10
ID18517A (id) 1998-04-16
SI0813876T1 (en) 2002-10-31
JP2923503B2 (ja) 1999-07-26
KR980000466A (ko) 1998-03-30
JP2855135B2 (ja) 1999-02-10
CN1178106A (zh) 1998-04-08
DE69711267T2 (de) 2002-11-21
KR0183449B1 (ko) 1999-05-01
ATE214937T1 (de) 2002-04-15
JPH11100326A (ja) 1999-04-13
EP0813876A1 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
GB9613858D0 (en) Hydrophobic preparations
ZA975448B (en) Cyclosporin-containing soft capsule preparations
PL330869A1 (en) Non-aqueous protical peptide preparations
PL330903A1 (en) Aqueous preparations of peptides
IL139235A0 (en) Pharmaceutical preparations
AU2721897A (en) Anti-cryptosporidium parvum preparations
PL330348A1 (en) Peptidic derivatives
EP0765165A4 (en) PREVENTED PEPTIDES
HUP9801109A3 (en) Cyclosporin-containing soft capsule preparations
PL328486A1 (en) Peptidic derivatives
PL318017A1 (en) Peptides
IL123153A0 (en) Antigenic preparations
PL340555A1 (en) Preparations containing dissolved paroxetin
GB2331521B (en) Vaccine preparations
AU125644S (en) Capsule
GB9425380D0 (en) Peptides
GB9413751D0 (en) Immunodominant peptides
HUP9801021A3 (en) Cyclosporin-containing soft capsule preparations
GB9519511D0 (en) Peptides
AU5948698A (en) Cyclosporin-containing soft capsule preparations
IL115197A0 (en) Vaccine preparations
GB9425381D0 (en) Peptides
IL111853A0 (en) Dental preparations
AUPO306596A0 (en) Time capsule
GB9608430D0 (en) Peptides